发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 1164 |
| Italy | 209 |
| France | 197 |
| GERMANY (FED REP GER) | 160 |
| Spain | 146 |
| England | 130 |
| Canada | 118 |
| Egypt | 106 |
| Australia | 97 |
| India | 91 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 246 |
| HARVARD UNIVERSITY | 178 |
| DANA-FARBER CANCER INSTITUTE | 156 |
| MAYO CLINIC | 104 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 87 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 84 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APH... | 81 |
| H LEE MOFFITT CANCER CENTER & RESEARCH ... | 79 |
| NATIONAL & KAPODISTRIAN UNIVERSITY OF A... | 70 |
| WASHINGTON UNIVERSITY (WUSTL) | 66 |
文章引用情况
1
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries2
Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis3
Comparison of Sebia Free Light Chain Assay With Freelite Assay for the Clinical Management of Diagnosis, Response, and Relapse Assessment in Multiple Myeloma4
Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France5
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma6
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes7
Prognostic Value of 1q21 Gain in Multiple Myeloma8
Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways9
Ruxolitinib Rechallenge Can Improve Constitutional Symptoms and Splenomegaly in Patients With Myelofibrosis: A Case Series10
TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma